Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

CANCvsFMEDETF Comparison

ETF 1
CANC

Tema Oncology ETF

This fund is part of
Tomorrow's Treatments
+0.45%
VS
ETF 2
FMED

Fidelity Disruptive Medicine ETF

This fund is part of
Multiple Trends
+0.2%

Tema Oncology ETF (CANC) belongs to the Tomorrow's Treatments segment. Fidelity Disruptive Medicine ETF (FMED) is part of the Multiple Trends segment. Both ETFs have the same top 3 sector exposures: and Healthcare. CANC is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.5% for FMED. CANC is up 18.41% year-to-date (YTD) with +$52M in YTD flows. FMED performs worse with 4.78% YTD performance, and -$17M in YTD flows. Run a side-by-side ETF comparison of CANC and FMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

CANC vs FMED performance and flow charts

Performance

-2.00.02.04.06.0%Jun 29Jul 7Jul 14Jul 21

Cumulative Flows

-8,000,000-6,000,000-4,000,000-2,000,0000Jun 29Jul 7Jul 14Jul 21

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/27/2026
1M3MYTD1Y3Y5Y
Perf.
CANC
FMED
-0.28%-0.72%
+8.61%+13.05%
+18.41%+4.78%
+53.77%+18.10%
n/a+13.64%
n/an/a
Flows
CANC
FMED
-$2M-
+$3M-$17M
+$52M-$17M
+$76M-$14M
--$6M
--
Volatility and drawdown
3M1Y3Y5Y
Volatility
CANC
FMED
+23.01%+22.48%
+22.71%+19.53%
n/a+18.59%
n/an/a
Max drawdown
CANC
FMED
-5.93%-5.92%
-9.20%-17.78%
n/a-21.42%
n/an/a
Max drawdown duration
CANC
FMED
47d18d
67d212d
n/a211d
n/an/a
Trading data

Create an account to view trading data

Join for free
CANC
FMED
Last sale
7/28/2026 at 1:30 PM
$41.18
Previous close
07/27/2026
$41.10
Consolidated volume
07/27/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Advertisement
Main metrics
Last update 7/28/2026 at 1:30 PM
Live
Closed
CANC
FMED
Last price
$41.18
1D performance
+0.20%
AuM$195.62 M$46.10 M
E/R0.99%0.5%
Characteristics
CANC
FMED
Management strategyActiveActive
ProviderTemaFidelity
Benchmark--
N° of holdings5669
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateAugust 15, 2023June 12, 2023
ESGNoNo
Advertisement
Exposure

Countries

CANC
USA
80.59%
Switzerland
9.85%
Other
9.56%
FMED
USA
83.89%
Other
16.11%

Sectors

CANC
Healthcare
99.28%
Other
0.72%
FMED
Healthcare
100%
Other
-0%
Advertisement

Diversification

CANC

Total weight of top 15 holdings out of 15

55.76%
FMED

Total weight of top 15 holdings out of 15

41.87%

Top 15 holdings

Data as of June 30, 2026
CANC
Revolution Medicines, Inc.
6.32%
Eli Lilly & Co.
5.24%
Cogent Biosciences, Inc.
4.94%
Novartis AG
4.19%
Roche Holding AG
3.93%
Legend Biotech Corp.
3.70%
Merck & Co., Inc.
3.66%
Bristol Myers Squibb Co.
3.33%
AstraZeneca PLC
3.15%
Johnson & Johnson
3.09%
AbbVie, Inc.
3.08%
Immunome, Inc.
2.87%
Exelixis, Inc.
2.85%
Nuvalent, Inc.
2.73%
IDEAYA Biosciences, Inc.
2.68%
FMED
Lifestance Health Group, Inc.
5.11%
10X Genomics, Inc.
3.56%
Danaher Corp.
3.29%
UCB SA
3.09%
Cogent Biosciences, Inc.
2.79%
Bio-Techne Corp.
2.76%
Moderna, Inc.
2.69%
Intuitive Surgical, Inc.
2.49%
argenx SE
2.43%
Alnylam Pharmaceuticals, Inc.
2.41%
Kymera Therapeutics, Inc.
2.36%
UnitedHealth Group, Inc.
2.27%
Thermo Fisher Scientific, Inc.
2.24%
Ascendis Pharma A/S
2.21%
Legend Biotech Corp.
2.17%
Frequently asked questions about CANC and FMED

How have the CANC and FMED ETFs performed in 2026?

As of July 27, 2026, CANC is up 18.41% year-to-date (YTD), while FMED has returned 4.78%. That puts CANC better performer ahead so far this year.

Which ETF is attracting more investor money: CANC or FMED?

Year-to-date, the CANC ETF saw +$52M in flows, compared to -$17M for FMED.

Which ETF is more volatile: CANC or FMED?

Over the past year, CANC had a volatility of 22.71%, while FMED experienced 19.53%.

Which ETF is bigger: CANC or FMED?

As of July 27, 2026, CANC holds $195.62 M in assets under management (AUM), while FMED manages $46.10 M.

What sectors do the CANC and FMED ETFs invest in?

CANC leans toward sectors like Healthcare. Meanwhile, FMED focuses on Healthcare.

What are the top holdings of the CANC ETF and FMED ETF?

CANC top holdings include Revolution Medicines, Inc., Eli Lilly & Co. and Cogent Biosciences, Inc.. FMED holds in its top three: Lifestance Health Group, Inc., 10X Genomics, Inc. and Danaher Corp..

Which ETF is more diversified: CANC or FMED?

CANC holds 56 securities with 55.76% of its assets in the top 15. FMED has 69 securities and a top 15 weight of 41.87%.

Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026